DAP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.511600E-01
Normal-vs-Stage2
8.091000E-01
Normal-vs-Stage3
6.523000E-01
Normal-vs-Stage4
3.350800E-01
Stage1-vs-Stage2
5.018400E-01
Stage1-vs-Stage3
7.878200E-01
Stage1-vs-Stage4
3.269800E-01
Stage2-vs-Stage3
3.345600E-01
Stage2-vs-Stage4
4.061000E-01
Stage3-vs-Stage4
2.411200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.362600E-01
Normal-vs-AfricanAmerican
1.764550E-01
Normal-vs-Asian
7.691000E-01
Caucasian-vs-AfricanAmerican
5.742100E-02
Caucasian-vs-Asian
5.241000E-01
AfricanAmerican-vs-Asian
3.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.485000E-01
Normal-vs-Female
9.131800E-01
Male-vs-Female
7.431400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.839600E-01
Normal-vs-Age(41-60Yrs)
7.222600E-01
Normal-vs-Age(61-80Yrs)
9.464800E-01
Normal-vs-Age(81-100Yrs)
6.202800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.147700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.003600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.898200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.764600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.824800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.828400E-01
Normal-vs-Daily Drinker
7.407000E-01
Normal-vs-Weekly Drinker
8.048200E-01
Normal-vs-Occasional Drinker
3.357800E-01
Normal-vs-Social Drinker
9.143200E-01
Non Drinker-vs-Daily Drinker
5.040800E-01
Non Drinker-vs-Weekly Drinker
7.016200E-01
Non Drinker-vs-Occasional Drinker
1.723650E-01
Non Drinker-vs-Social Drinker
9.167800E-01
Daily Drinker-vs-Weekly Drinker
3.103400E-01
Daily Drinker-vs-Occasional Drinker
2.717700E-02
Daily Drinker-vs-Social Drinker
4.191800E-01
Weekly Drinker-vs-Occasional Drinker
3.681200E-01
Weekly Drinker-vs-Social Drinker
7.518400E-01
Occasional Drinker-vs-Social Drinker
1.416760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.738800E-01
Normal-vs-Grade 2
6.965000E-01
Normal-vs-Grade 3
6.856000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.682500E-03
Grade 1-vs-Grade 3
1.065710E-02
Grade 1-vs-Grade 4
8.738800E-01
Grade 2-vs-Grade 3
8.159600E-01
Grade 2-vs-Grade 4
6.965000E-01
Grade 3-vs-Grade 4
6.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.875000E-01
Normal-vs-NonDiabetic
8.710600E-01
Diabetic-vs-NonDiabetic
6.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.257800E-01
Normal-vs-NoPancreatitis
9.199000E-01
Pancreatitis-vs-NoPancreatitis
2.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.571800E-01
Normal-vs-N1
9.385200E-01
N0-vs-N1
1.484420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.983600E-01
Normal-vs-TP53-NonMutant
9.095400E-01
TP53-Mutant-vs-TP53-NonMutant
6.419900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
